However, 12% of patients (n = 4) had a grade 3 or 4 rise in creatinine, 3% of patients (n = 1) developed grade 3 or 4 hypokalaemia and 3% of patients (n = 1) had a grade 3 or 4 rise in ALT during treatment. The gene discussed is GPT; the disease is Hypokalemia.